» Articles » PMID: 18697776

Vitamin D and Chronic Widespread Pain in a White Middle-aged British Population: Evidence from a Cross-sectional Population Survey

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2008 Aug 14
PMID 18697776
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Identified aetiological factors for chronic widespread pain (CWP) are largely related to emotional and behavioural factors, but current management leads to modest improvement in symptoms. Vitamin D deficiency has been suggested as a new modifiable risk factor for CWP.

Objective: To examine the association between vitamin D status (measured by 25-hydroxyvitamin D (25(OH)D)) and CWP in a nationwide population sample of white British adults, accounting for potential mediating and confounding lifestyle factors.

Methods: 9377 participants born 1 week in March 1958, in England, Scotland or Wales and completing a biomedical assessment at age 45; 6824 eligible participants had data on 25(OH)D and completed pain manikins.

Results: Prevalence of CWP varied by 25(OH)D concentration in women but not in men, with the lowest prevalence observed for women with 75-99 nmol/l (14.4% for <25 nmol/l, 14.8% for 25-49 nmol/l, 11.6% for 50-74 nmo/l, 8.2% for 75-99 nmol/l and 9.8% for participants with > or =100 nmol/l). There was an interaction between 25(OH)D concentration and gender in relation to CWP (interaction, p = 0.006), which was not fully explained by differences in lifestyle or social factors (adjusted interaction, p = 0.03). For women, the association between 25(OH)D concentration and CWP persisted after full adjustment (odds ratio (OR) for <75 nmol/l vs 75-99 nmol/l 1.57, 95% CI 1.09 to 2.26), while no evidence for an association was apparent in men (OR = 1.03, 95% CI 0.75 to 1.43).

Conclusion: Current vitamin D status was associated with CWP in women but not in men. Follow-up studies are needed to evaluate whether higher vitamin D intake might have beneficial effects on the risk of CWP.

Citing Articles

Baseline Vitamin D Levels on Quality of Life and Pain Perception Among Patients with Chronic Pain with Long-Term Prescription Opioid Use: A Prospective Study.

Laubner Sakalauskiene G, Straznickaite I, Miskinyte S, Zdanavicius L, Sipylaite J, Badaras R J Clin Med. 2025; 14(2).

PMID: 39860651 PMC: 11766184. DOI: 10.3390/jcm14020645.


Relationship Between Serum Vitamin D Levels and Chronic Musculoskeletal Pain in Adults: A Systematic Review.

Alonso-Perez J, Martinez-Perez I, Romero-Morales C, Abuin-Porras V, Lopez-Bueno R, Rossettini G Nutrients. 2024; 16(23).

PMID: 39683456 PMC: 11643417. DOI: 10.3390/nu16234061.


Vitamin D and Its Role on the Fatigue Mitigation: A Narrative Review.

Di Molfetta I, Bordoni L, Gabbianelli R, Sagratini G, Alessandroni L Nutrients. 2024; 16(2).

PMID: 38257114 PMC: 10818509. DOI: 10.3390/nu16020221.


A Comprehensive Review of the Genetic and Epigenetic Contributions to the Development of Fibromyalgia.

Ovrom E, Mostert K, Khakhkhar S, McKee D, Yang P, Her Y Biomedicines. 2023; 11(4).

PMID: 37189737 PMC: 10135661. DOI: 10.3390/biomedicines11041119.


Psychological Outcomes and Quality of Life of Fibromyalgia Patients with Vitamin D Supplementation-A Meta-Analysis.

Yang C, Tsai S, Ting B, Cheng Y, Wang C, Chang J J Clin Med. 2023; 12(7).

PMID: 37048833 PMC: 10095322. DOI: 10.3390/jcm12072750.